Gastrointestinal Endoscopy in Patients With Prothrombotic Conditions: THE ENDOHEM REGISTRY

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1602 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-01-01

Study Completion Date

2020-05-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This observational study evaluates the safety of gastrointestinal endoscopy in patients on oral anticoagulants (Vitamin K antagonists, rivaroxaban, dabigatran, edoxaban, and apixaban). This registry aims to assess the incidence, characteristics and risk factors for cardiovascular and bleeding events associated with an endoscopic procedure. Besides, it aims to evaluate the differences between Vitamin K antagonists and DOACs users and to estimate the impact of anticoagulation withdrawal time on the primary and secondary outcomes.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Incidence of Late Haemorrhage After Invasive Gastroenterological Endoscopic Manoeuvre in Patients Treated With Anticoagulants Compared to Non-anticoagulated Patients

NCT07019077

Bleeding

RECRUITING

Study of the Risk Factors and Outcomes After Gastrointestinal Bleeding

NCT02514304

Gastrointestinal Hemorrhage Cardiovascular Diseases

COMPLETED

Anticoagulant Clinics and Vitamin K Antagonists

NCT00966290

Blood Coagulation Disorders

COMPLETED PHASE4

Comparative Study of the Hemorrhagic Risk in Patients Over 75 Years of Age Taking Enoxaparin

NCT05150314

Venous Thromboembolic Disease

UNKNOWN

Compare VKA vs LMWH in Patients With Anticoagulation Criteria and Episode of Gastrointestinal Bleeding.

NCT01727453

Acute Gastrointestinal Bleeding

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gastrointestinal Bleeding Cardiovascular Complication Anticoagulants; Circulating, Hemorrhagic Disorder Gastrointestinal Endoscopy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Elective endoscopy

Patients undergoing gastrointestinal endoscopy unrelated to anticoagulant-induced gastrointestinal bleeding.

Gastrointestinal endoscopy

Intervention Type PROCEDURE

Two separated groups will be included in the registry:

1. Patients with oral anticoagulants-induced gastrointestinal bleeding unrelated to an endoscopic procedure.
2. Patients undergoing elective gastrointestinal endoscopy.

Gastrointestinal bleeding

Patients with anticoagulant-induced gastrointestinal bleeding will be analyzed separately

Gastrointestinal endoscopy

Intervention Type PROCEDURE

Two separated groups will be included in the registry:

1. Patients with oral anticoagulants-induced gastrointestinal bleeding unrelated to an endoscopic procedure.
2. Patients undergoing elective gastrointestinal endoscopy.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.